2 models fit Slide Insurance Holdings Inc. Common Stock and they disagree: 0 of 2 land within 15% of the average. The price is below every model.
Two or more of our models back this value.
Large discount(i)Silver72
Valued as an insurer: Residual income and P/E comparison.
ACCE opinionSlide Insurance Holdings Inc. Common Stock (SLDE)
Fair value (2 models)
$54.43
ACCE price target
$28.00
Rating
Undervalued
Horizon
12 months
Fair value published on 16 Oct 2026, 00:00 CEST; previously $35.30 since 5 Oct 2026, 00:00 CEST.
ACCE price target published on 11 Oct 2026, 00:00 CEST.
Rating published on 21 Oct 2026, 11:06 CEST.
Price used: $28.55 at the close on 23 Oct 2026, 22:00 CEST.
Models: P/E comparison and Residual income.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
47.5% below
+90.6% to fair value
ACCE score
88
out of 100
Analysts
80% buy
5 covering
P/E
6.9x
forward 7.8x
1-year return
+83.6%
Dividend yield
1.01%
Slide Insurance Holdings Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Slide Insurance writes residential property coverage for homeowners in Florida, a market where most carriers have retreated from the state after repeated hurricane losses, leaving the insurer of last resort and newer private carriers to fill the gap. The company's edge is its risk-sharing structure with reinsurers and its focus on a single peril-exposed state, which lets it price rates upward as competitors exit. Revenue grew 47.9% over the latest reported period, and return on equity reached 53.9% with an operating margin of 46.4%, figures that reflect both rate increases and a thin field of competitors. The near-term catalyst is the June 1 reinsurance renewal, where the cost of catastrophe protection for the 2025 season sets the earnings base for the year ahead. A 6.4 trailing P/E on a $3.1B market cap is cheap for a company growing this fast, but the market is pricing in a single bad hurricane season, so the question for the deeper look is how much of this earnings power survives a large storm.
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
moderate
Insider selling without buying
Insiders sold $4.75M across the last 10 disclosed transactions and bought nothing. Insiders hold 43.9% of the stock, so selling is worth tracking even at this size.
moderate
Short interest elevated
Short interest stands at 11.2% of shares. That is a sizeable bearish bet against a stock that has already grown revenue 47.9% year on year.
moderate
Score slipping over 90 days
The ACCE score fell from 91 to 88 over 90 days, with the valuation sub-score at 56 against 100 for growth and quality.
AI research notes
AI-assisted·How I use AIWritten Oct 18, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Revenue grew 47.9% year over year, and the five-year average annual growth rate is 68.3%.
Net margin of 40.0% and return on equity of 53.9% show the business turns sales into unusually high profit.
Free cash flow of $795M over the last twelve months, against a free cash flow yield of 25.6%, looks very large for the share price.
Why it could disappoint
Share count rose 10.7% in the last fiscal year, so each shareholder's slice of earnings shrank.
Analysts' mean price target of $26.40 sits 2.5% below the share price, so the Street sees little upside.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Oct 27, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where SLDE's valuation models land
Price
$28.55
Model fair value
$54.43
Model range
$47.13 to $69.02
Fair value $54.43
Price $28.55
The price is below the whole model range.
Model
Fair value
Upside
P/E comparison
Residual income
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores